Drugs & Pharmaceuticals

In 2019, I wrote an article called "4 Prescription Drugs People Hate." It was rather popular.

The FDA just approved a new sleeping pill – the second in a class that works by a novel mechanism – a dual orexin receptor antagonist.

OK, I may have taken some license with the title but not with the science.

ACSH friend Dr. Vanila Singh, the former Chief Medical Officer for the Office of the Assistant Secretary for Health at the U.S.

Lately I have become intrigued by the word, innovation. Innovation is used as a criterion for funding grants, for status in reviews of our antibiotic pipeline, for intelligence, imagination and many other great things.

A new paper from the Progressive Policy Institute, a Washington-based think tank, describes a “prescription escalator” to explain the apparent rising cost of pharmaceuticals. Let’s hit a few highlights

Just about any drug can be made to look bad, especially when its risks are considered in the absence of its benefits.

Sometimes a picture does say so much more than words.

October 31st will mark the 37th anniversary of one of biotechnology’s most significant milestones -- the approval by the FDA of human insulin synthesized in genetically engineered bacteria.  It launched a revolutionary ne

On October 15th, Medicare’s version of trick or treat opens its doors. From that date until December 7th, Medicare beneficiaries have the option and opportunity to modify their out-of-pocket costs for the next year.